Home Search
ovarian cancer - search results
If you're not happy with the results, please do another search
Viome, Helomics Partner on Personalized Ovarian Cancer Treatments
The two companies will study the link between ovarian cancer and the gut microbiome with the hopes of guiding personalized treatments
Ovarian Cancer Prognosis Improved via AI
Researchers say tool is more accurate at predicting ovarian cancer prognosis than current methods and pinpoints more effective treatments
Detection of Ovarian Cancer Recurrence: Quality Control Routines using an Integrated Proteomics Approach
The webinar will focus on some of the current challenges facing researchers looking to improve biomarker discovery for ovarian cancer.
Myriad to Use BRACAnalysis CDx as Companion Diagnostic for Clovis’ Ovarian Cancer Treatment
Collaboration is intended to fulfill a post-approval regulatory commitment by Clovis to the FDA for Rubraca (rucaparib).
Color Genomics Launches Benefits Program for Breast, Ovarian Cancer Risk Testing
Today Color Genomics unveiled the Benefits Program for Genetic Testing for Breast and Ovarian Cancer Risk, a first-of-its-kind initiative to offer this type of...
More Ovarian Cancer Detected if Biomarker Velocities Are Scrutinized
A single biomarker plus a fixed threshold may equal a missed diagnosis—actually, a great many missed diagnoses. But fixed thresholds aren’t inevitable. For example,...
Machine Learning Aids Detection of Cancerous Ovarian Lesions
Researchers have used machine learning to leverage ultrasound features of ovarian lesions to train a new model that can recognize whether a lesion is benign or cancerous using reconstructed images taken from photoacoustic tomography.
Time of Day May Be Important for Cancer Diagnosis and Treatment
Key biologic features of tumor progression are influenced by the circadian rhythm, which could be used to optimize timing of drug delivery and maximize safety and efficacy.
Duchenne Muscular Dystrophy Gene Linked to Cancer
New research links the X-chromosome gene DMD, mutations in which cause Duchenne muscular dystrophy, to a range of different cancers.
New Data Shows How Germline Interacts with Somatic Mutations in Cancer
New data suggests specific germline-somatic associations can affect cancer development.
